Cleared Traditional

K221725 - Advanced MyHip Planner

K221725 is the FDA 510(k) clearance for Advanced MyHip Planner by Medacta International S.A.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 220-day FDA review.

K221725 · Medacta International S.A. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2023
Decision
220d
Days
Class 2
Risk

K221725 is an FDA 510(k) clearance for the Advanced MyHip Planner. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro (Ch), CH). The FDA issued a Cleared decision on January 20, 2023 after a review of 220 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Medacta International S.A. devices

Submission Details

510(k) Number K221725 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 2022
Decision Date January 20, 2023
Days to Decision 220 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
113d slower than avg
Panel avg: 107d · This submission: 220d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Medacta USA
Chris Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1091
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K221725.
syngo.via View&GO VA40A
K230196 · Siemens Healthcare GmbH · Feb 2023
MD.ai Viewer
K223425 · Mdai, Inc. · Feb 2023
Atomica Planner
K230012 · Atomica Technology, Inc. · Feb 2023
PerfusionGo Plus
K221627 · Yukun (Beijing) Technology Co., Ltd. · Jan 2023
TruPlan Computed Tomography (CT) Imaging Software
K222593 · Circle Cardiovascular Imaging, Inc. · Jan 2023
Elucis
K220649 · Realize Medical, Inc. · Jan 2023